These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37841540)

  • 1. Relation of Vitamin D levels with positive and negative symptoms of schizophrenia - A hospital based cross-sectional comparative study.
    Ghosh S; Deka B
    Indian J Psychiatry; 2023 Sep; 65(9):955-960. PubMed ID: 37841540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship between Symptom Severity and Low Vitamin D Levels in Patients with Schizophrenia.
    Doğan Bulut S; Bulut S; Görkem Atalan D; Berkol T; Gürçay E; Türker T; Aydemir Ç
    PLoS One; 2016; 11(10):e0165284. PubMed ID: 27788194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia.
    Graham KA; Keefe RS; Lieberman JA; Calikoglu AS; Lansing KM; Perkins DO
    Early Interv Psychiatry; 2015 Oct; 9(5):397-405. PubMed ID: 24612563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between serum 25-hydroxyvitamin D level and core symptoms of autism spectrum disorder in children].
    Dong HY; Wang B; Li HH; Shan L; Jia FY
    Zhonghua Er Ke Za Zhi; 2017 Dec; 55(12):916-919. PubMed ID: 29262471
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation.
    Yüksel RN; Altunsoy N; Tikir B; Cingi Külük M; Unal K; Goka S; Aydemir C; Goka E
    Ther Adv Psychopharmacol; 2014 Dec; 4(6):268-75. PubMed ID: 25489478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlations between hormone levels and psychiatric symptoms as well as cognitive function in drug-free first-episode schizophrenics].
    Yuan XX; Zhu QY; Liang HB; Hei GR; Li X; Pang LJ; Li HH; Li H; Song XQ
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(27):2155-60. PubMed ID: 27464540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of serum homocysteine and vitamin D with positive, negative, and extrapyramidal symptoms in schizophrenia: a case-control study in Iran.
    Shahini N; Jazayeri SMMZ; Jahanshahi R; Charkazi A
    BMC Psychiatry; 2022 Nov; 22(1):681. PubMed ID: 36333678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of immune status in relation to vitamin D levels in children on regular hemodialysis.
    Youssef DM; Elshal AS; Abo Elazem AA
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):267-73. PubMed ID: 22382217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D Levels in Different Severity Groups of Schizophrenia.
    Akinlade KS; Olaniyan OA; Lasebikan VO; Rahamon SK
    Front Psychiatry; 2017; 8():105. PubMed ID: 28659835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of Vitamin D supplementation in Iranian patients with schizophrenia: Effects on serum levels of glycogen synthase kinase-3β and symptom severity.
    Kalejahi P; Kheirouri S; Noorazar SG
    Int J Psychiatry Med; 2023 Nov; 58(6):559-575. PubMed ID: 37545122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low serum vitamin D concentrations in patients with schizophrenia.
    Itzhaky D; Amital D; Gorden K; Bogomolni A; Arnson Y; Amital H
    Isr Med Assoc J; 2012 Feb; 14(2):88-92. PubMed ID: 22693787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Klotho, vitamin D and homocysteine levels during acute episode and remission periods in schizophrenia patients.
    Yazici E; Mutu Pek T; Guzel D; Yazici AB; Akcay Ciner O; Erol A
    Nord J Psychiatry; 2019 Apr; 73(3):178-184. PubMed ID: 30896269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The psychotropic effect of vitamin D supplementation on schizophrenia symptoms.
    Neriman A; Hakan Y; Ozge U
    BMC Psychiatry; 2021 Jun; 21(1):309. PubMed ID: 34130647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Comparison Between Positive and Negative Symptoms Severity in Prolonged Methamphetamine-induced Psychotic Disorder and Schizophrenia.
    Ahmadkhaniha H; Ayazi N; Alavi K; Najjarzadehgan M; Hadi F
    Basic Clin Neurosci; 2022; 13(3):325-333. PubMed ID: 36457876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the relationship between serum levels of 25-hydroxyvitamin D and prognostic factors in breast cancer.
    Heiranizadeh N; Alavizadeh FS; Jafari Nodooshan J; Neshan M
    Pol Przegl Chir; 2022 Aug; 95(2):1-5. PubMed ID: 36805306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Levels of 25-hydroxyvitamin D in Chronic Urticaria and its Association with Disease Activity: A Case Control Study.
    Rather S; Keen A; Sajad P
    Indian Dermatol Online J; 2018; 9(3):170-174. PubMed ID: 29854636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Vitamin D Levels and Status in Thai Optic Neuritis Subjects: A Case-Control Study.
    Puangsricharoen B; Vanikieti K; Jindahra P; Padungkiatsagul T
    Clin Ophthalmol; 2022; 16():3381-3389. PubMed ID: 36249444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.